Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Neuralstem Inc.
ClinicalTrials.gov Identifier:
NCT01348451
First received: April 28, 2011
Last updated: March 9, 2016
Last verified: March 2016